Fresenius Medical Care AG & Co. KGaA

Earnings Release • Dec 14, 2011

Corporate Profile

Fresenius Medical Care

Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2 million individuals worldwide. Through its network of 2,874 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 228,239 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.

Growth Strategy

With GOAL 13…

…new targets of the growth strategy were adopted in September 2010. Thereby we follow up the previous strategy, continuing to pursue the strategic four paths consistently in a financially responsible way to consolidate our position as world market leader in dialysis:

• Organic growth in dialysis services by innovative treatment techniques and the opening of new clinics
• Acquisitions of existing clinics to ensure optimized international presence
• Horizontal expansion in the sector of Renal Drugs as well as
• A boosted activity in home therapies

Key Figures - Summary Third Quarter 2011

Net revenue	\$ 3,242 million	+ 6%
Operating income (EBIT)	\$ 534 million	+ 8%
Net income attributable to Fresenius Medical Care AG & Co. KGaA	\$ 279 million	+ 13%
Earnings per share	\$ 0.92	+ 12%
Total assets1	\$ 18,625 million
Operating cash flow2	\$ 950 million
Employees1	77,825	+ 6%
Patients1	228,239	+ 9%
Clinics1	2,874	+ 6%
Treatments2	25.46 million	+ 9%

1 as of September 30, 2011

2 in the first nine months of 2011

Revenue Q3 2011 per region (\$ 3,242 m)

Goals for 2011

Net revenue	> \$ 13.0 billion
Net income	\$ 1.070 - 1.090 billion
Leverage ratio (Debt/EBITDA)	< 3.0
Capital expenditures	~ 5% of revenue
Acquisitions	~ \$ 1.9 billion

Management Board Supervisory Board

• Dr. Emanuele Gatti William P. Johnston

• Kent Wanzek

• Dr. Ben J. Lipps (Chairman) Dr. Gerd Krick (Chairman)

• Rice Powell (Vice Chairman) Dr. Dieter Schenk (Vice Chairman)
• Michael Brosnan Dr. Walter L. Weisman
• Roberto Fusté Rolf A. Classon
• Dr. Rainer Runte Prof. Dr. Bernd Fahrholz

Share Profile – Key Data

	Ordinary shares	Preference shares
Ticker Symbols
Frankfurt Stock Exchange	FME	FME3
New York Stock Exchange (NYSE)	FMS	FMS/P
Reuters: XETRA / Frankfurt Stock Exchange	FMEG.DE / FMEG.F	FMEG_p.DE / FMEG_p.F
Bloomberg	FME GY	FME3 GY
Security Identification Numbers
WKN	578 580	578 583
ISIN	DE 0005785802	DE 0005785836
CUSIP No. (NYSE)	358029106	358029205

Financing Instruments and Maturity Profile

	Year issued	Amount in million	Coupon %	Maturity
Credit Agreement Revolver		\$ 1,200		March 31, 2013
Credit Agreement Term Loan A		\$ 1,8501		March 31, 2013
Credit Agreement Term Loan B		\$ 1,7501		March 31, 2013
Senior Notes 2010 - 2016	2010	€ 250	5.50%	July 15, 2016
Senior Notes 2011 - 2016	2011	€ 100	3-month-Euribor	October 15, 2016
			+ 3.50%
Senior Notes 2007 - 2017	2007	\$ 500	6.875%	July 15, 2017
Senior Notes 2011 - 2018	2011	\$ 400	6.50%	September 15, 2018
Senior Notes 2011 - 2018	2011	€ 400	6.50%	September 15, 2018
Senior Notes 2011 - 2021	2011	\$ 650	5.75%	February 15, 2021
Senior Notes 2011 - 2021	2011	€ 300	5.25%	February 15, 2021
Notes (Schuldscheindarlehen)	2009	€ 155		October 27, 2012
Notes (Schuldscheindarlehen)	2009	€ 45		October 27, 2014
Accounts Receivable Facility		\$ 800		July 31, 2014

1 at the beginning before amortisation and extension

Share Price Development last 12 months Financial Calendar

	Event	Date
	Report on Third Quarter 2011
	Quarterly Financial Report:	Nov. 30, 2011
	Report on Fiscal Year 2011:	February 21, 2011
	Report on First Quarter 2012:	May 3, 2012
	Annual General Meeting 2012:	May 10, 2012
	Report on Second Quarter 2012:	August 1, 2012
01.11.10 01.01.11 01.03.11 01.05.11 01.07.11 01.09.11 01.11.11	Report on Third Quarter 2012:	October 31, 2012

Capital Structure Contacts

Fresenius Medical Care AG & Co. KGaA	Investor Relations & Corporate Communications
Else-Kröner-Straße 1	61352 Bad Homburg
Oliver Maier	P:+49(0)6172-609-2525
Senior Vice President, Head of IR & CC	F: +49(0)6172-609-2301
Gerrit Jost Vice President	P:+49(0)6172-609-5216
North America Terry L. Morris Vice President	P:+1-800-948-2538 F: +1-615-345-5605